• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 04/06/2023
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.  the device is assembled according to specifications.  in process and finished product testing are performed and approved prior to release.
 
Event Description
Provider performed a "very vigorous fundal massage and the jada device came out of the patient with the balloon still intact [device expulsion] case narrative: this initial spontaneous report originating from the united states, was received from a clinical educator via clinical account specialist (cas), referring to a non-pregnant female patient.The patient's medical history included pregnancy and delivery.Her concurrent conditions, past drugs/allergies, and concomitant medications were not reported.The patient had lost 2100 cc of blood at delivery prior to use of vacuum-induced hemorrhage control system (jada system).This report concerns 1 patient and 1 device.On (b)(6) 2023, the patient underwent vacuum-induced hemorrhage control system (jada system) via vaginal route (lot# and expiry date were not reported) placement by the provider for postpartum hemorrhage.It was reported that the suction was on and working and the canister was filling.The provider performed a "very vigorous fundal massage and the vacuum-induced hemorrhage control system (jada system) device came out of the patient with the balloon still intact" (device expulsion).The patient sought medical attention and ended up with a hysterectomy.It was unknown if the vacuum-induced hemorrhage control system (jada system) was available for evaluation.Upon internal review, the event of device expulsion was determined to be serious due to the following reasons: medically significant and required intervention.When the lot number is unknown, a technical investigation of the specific manufacturing process which includes review of records associated with a known lot number cannot be performed.Medical device reporting criteria: serious injury.Fda code: (health effects - health impact per annex f): 4624 surgical intervention (one or more surgical procedures was required, or an existing procedure changed).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16866494
MDR Text Key314528361
Report Number3002806821-2023-00046
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient SexFemale
-
-